Vestack’s Over €10 Million Financing

Goodwin Procter advised Vestack on the deal. Chammas & Marcheteau advised Mirova. Vestack, a tech company specializing in the design and construction of low-carbon buildings, announced its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

EcoVadis’ $500 Million Fundraising

Jones Day advised EcoVadis on the deal. Orrick advised Princeville Capital. Goodwin Procter represented Astorg. EcoVadis, a leading global sustainability rating firm, announced its $500 million fundraising....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Germitec’s €11 Million Financing Round

Goodwin advised Germitec on the deal. Germitec, a global healthcare leader in high-Level UV-C disinfection systems, announced the financing round of €11 million. Reference investors in the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Exegy’s Acquisition of Enyx

Aramis advised the sellers on the transaction. Exegy and Marlin Equity Partners were advised by Goodwin Procter. Exegy, a portfolio company of Marlin Equity Partners, a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Mila’s €4 Million Financing

Dechert advised the investor on the deal. Kurma Partners, BNP Paribas Développement and Bpifrance through its fund Patient Autonomy, completed their investment of a total amount of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Biomunex Pharmaceuticals’ Agreement with Onward Therapeutics and Series A Fundraising

Dechert advised Biomunex Pharmaceuticals on the deal. Biomunex Pharmaceuticals, a French biopharmaceutical company, closed a strategic exclusive worldwide license and co-development agreement with Onward Therapeutics SA...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here